Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tianhuang formula reduces the oxidative stress response of NAFLD by regulating the gut microbiome in mice
Duosheng Luo, Ling Yang, Huiting Pang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 20

Showing 20 citing articles:

Gut microbiota: A new key of understanding for Panax notoginseng against multiple disorders and biotransformation
Y. J. Mo, Xiao-Tao He, Hao Cui, et al.
Journal of Ethnopharmacology (2025) Vol. 341, pp. 119306-119306
Closed Access | Times Cited: 1
Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development
Lu Wang, Yonghuan Yan, Linfang Wu, et al.
Pharmacological Research (2023) Vol. 196, pp. 106925-106925
Open Access | Times Cited: 24
Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
Xin Ding, Xu He, Bulang Tang, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 9
The dysfunction in intestinal microorganisms and enzyme activity as significant contributors to diarrhea with kidney-yang deficiency syndrome
Mengsi Zhou, Xiaoya Li, Xuehong Wang, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 7
Therapeutic Effects of Natural Products in the Treatment of Chronic Diseases: The Role in Regulating KEAP1–NRF2 Pathway
Yaling Li, Xihua Wang, Shuyue Li, et al.
The American Journal of Chinese Medicine (2025), pp. 1-30
Closed Access
Exposure to synthesized tribromobisphenol A and critical effects: Metabolic pathways, disease signature, and benchmark dose derivation
Hong-Xuan Kuang, Chenyin Dong, Lei Yan, et al.
The Science of The Total Environment (2024) Vol. 932, pp. 173117-173117
Closed Access | Times Cited: 4
Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-κB signaling pathway
Tian Lan, Bo Chen, X. Hu, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117516-117516
Closed Access | Times Cited: 9
Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm
Damien Chua, Zun Siong Low, Guo Xiang Cheam, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14762-14762
Open Access | Times Cited: 12
The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review
Kiana Mohammadian, Fatemeh Fakhar, Shayan Keramat, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 797-797
Open Access | Times Cited: 2
Decoding the role of immune T cells: A new territory for improvement of metabolic‐associated fatty liver disease
Jia Liu, Mingning Ding, Jinzhao Bai, et al.
iMeta (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 6
Exploring global research status and trends in anti-obesity effects of traditional Chinese medicine through intestinal microbiota: a bibliometric study
Wenjing Huang, Jiuyuan Wang, Min Kuang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
Integrating network analysis and pharmacokinetics to investigate the mechanisms of Danzhi Tiaozhi Decoction in metabolic-associated fatty liver disease (MAFLD)
Xiaofei Jiang, Nannan Tang, Yuyu Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117008-117008
Open Access | Times Cited: 5
Assessment of metabolomic variations among individuals returning to plain areas after exposure to high altitudes: a metabolomic analysis of human plasma samples with high-altitude de-acclimatization syndrome
Zhen Tan, Pan Shen, Yi Wen, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Aucubin ameliorates atherosclerosis by modulating tryptophan metabolism and inhibiting endothelial-mesenchymal transitions via gut microbiota regulation
Zhizhong Luo, Ling Yang, Tianxin Zhu, et al.
Phytomedicine (2024) Vol. 135, pp. 156122-156122
Closed Access | Times Cited: 1
Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease
Yuqiao Liu, Yue Fan, Ji‐Bin Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
High-Fat Diet Led to Testicular Inflammation and Ferroptosis Via Modulation of Gut-Testis Axis
Zelin Zhang, Huali Chen, Qingwang Li
(2024)
Closed Access
WeiNaiAn capsule attenuates intestinal mucosal injury and regulates gut microbiome in indomethacin-induced rat
Yanqiu Zheng, Jinbin Song, Lili Huang, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 173, pp. 106609-106609
Closed Access
High-fat diet led to testicular inflammation and ferroptosis via dysbiosis of gut microbes
Zelin Zhang, Huali Chen, Qingwang Li
International Immunopharmacology (2024) Vol. 142, pp. 113235-113235
Closed Access
Chinese herbal formula in the treatment of metabolic dysfunction-associated steatotic liver disease: current evidence and practice
Shaohong Tao, Yu‐Qing Lei, Yimei Tan, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation
Chin Long Poo, Mei Siu Lau, Nur Liana Md Nasir, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 10, pp. 11460-11502
Open Access
Page 1

Scroll to top